Access cutting-edge chronic myelogenous leukemia treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.
Access chronic myelogenous leukemia specialists in Houston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic myelogenous leukemia treatment provided free
This is a long term safety study for patients who have completed a Novartis sponsored asciminib study and are judged by the investigator to benefit from continued treatment
Sponsor: Novartis Pharmaceuticals
Check if you qualify for this chronic myelogenous leukemia clinical trial in Houston, TX
If you're searching for chronic myelogenous leukemia treatment options in Houston, TX, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic myelogenous leukemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.